Supriya Lifescience gains ANVISA nod for Esketamine Hydrochloride & files patent for… EP News Bureau Dec 10, 2024 Supriya Lifescience has developed a technique for low-cost manufacturing of Atorvastatin
Zydus receives final approval from the USFDA for Darunavir Tablets 600 mg and 800 mg EP News Bureau Dec 15, 2023 Darunavir is a protease inhibitor antiviral medicine that prevents Human Immunodeficiency Virus (HIV-1) from multiplying in the…
Sanofi to focus on 12 blockbuster drug candidates, immunology pipeline Reuters Dec 8, 2023 The 12 blockbuster drugs include nine medicines and vaccines with 2 billion to 5 euros ($2.15-$5.38 billion) in peak sales…
Centre clarifies reasons for delay in approvals for remdesivir EP News Bureau Jun 15, 2020 Informs that it is awaiting data on some crucial parameters from companies that have applied for manufacturing and marketing…
ANDA approvals in 2019: Trends for the generics industry EP News Bureau Jan 16, 2020 Meenu Grover Sharma, Scholar Delhi Pharmaceutical Sciences & Research University, Principal Consultant, BusinessAssociar…